Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain.
Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain.
Best Pract Res Clin Rheumatol. 2019 Oct;33(5):101477. doi: 10.1016/j.berh.2019.101477. Epub 2020 Jan 25.
No published epidemiological study has specifically focused on the prevalence of established rheumatoid arthritis (RA), as epidemiologists do not study established RA separated from RA as a whole; especially no incidence studies can be found, as incidence refers to new cases (early RA). Such a study, if it existed, would find a prevalence much larger than that of recent-onset RA, and should be planned based on clear definitions that currently do not exist in epidemiology. As a result, any study addressing RA as a whole, leaving aside early arthritis, would be actually studying established RA. This work reviews the epidemiology of RA, in contraposition of early RA, and tried to highlight epidemiological characteristics of established RA in published studies as well as methodological issues, including differences between recent-onset and established RA regarding the prevalence of comorbidities and other characteristics, and differences across countries. The global epidemiology of established RA teaches us that long-term outcomes could largely depend on health care models and are modifiable.
目前尚无专门针对已确诊类风湿关节炎(RA)患病率的流行病学研究,因为流行病学家不会将已确诊 RA 与整体 RA 分开进行研究;特别是找不到发病率研究,因为发病率是指新发病例(早期 RA)。如果存在这样的研究,其结果会发现已确诊 RA 的患病率远高于新发病例,并且应该基于目前在流行病学中尚不存在的明确定义进行规划。因此,任何将 RA 作为一个整体进行研究而不考虑早期关节炎的研究,实际上都是在研究已确诊 RA。本工作回顾了 RA 的流行病学,与早期 RA 相对照,并试图突出已发表研究中已确诊 RA 的流行病学特征以及方法学问题,包括新发和已确诊 RA 在合并症和其他特征方面的患病率差异,以及各国之间的差异。已确诊 RA 的全球流行病学研究告诉我们,长期结果在很大程度上取决于医疗保健模式,并且是可以改变的。